OBJECTIVE: To assess time trends in use of surgery in patients with non-small cell lung cancer (NSCLC) in a UK region. METHODS: Cancer registration data for patients diagnosed with NSCLC between 1995 and 2006 in the East of England were analysed. Rates of surgery use for different age, gender, diagnosis period, tumour subtype and deprivation quintile groups were examined. RESULTS: The analysis included 18,767 patients with NSCLC. During the study period, 13% of patients were treated by surgery. Use of surgery decreased over time from 15% in 1995-1997 to 11% in 2004-2006 (p=0.022). Initial socioeconomic differences in surgery use narrowed significantly over time (p=0.028) and became non-apparent at the end of the study period. CONCLUSIONS: Use of surgery in patients with NSCLC decreased during the study period, possibly reflecting increasing quality of preoperative staging processes. Initial socioeconomic inequalities in surgery use became undetectable at the end of the study period. The findings provide baseline information to support comparisons with patterns of clinical management in more recent years.
OBJECTIVE: To assess time trends in use of surgery in patients with non-small cell lung cancer (NSCLC) in a UK region. METHODS: Cancer registration data for patients diagnosed with NSCLC between 1995 and 2006 in the East of England were analysed. Rates of surgery use for different age, gender, diagnosis period, tumour subtype and deprivation quintile groups were examined. RESULTS: The analysis included 18,767 patients with NSCLC. During the study period, 13% of patients were treated by surgery. Use of surgery decreased over time from 15% in 1995-1997 to 11% in 2004-2006 (p=0.022). Initial socioeconomic differences in surgery use narrowed significantly over time (p=0.028) and became non-apparent at the end of the study period. CONCLUSIONS: Use of surgery in patients with NSCLC decreased during the study period, possibly reflecting increasing quality of preoperative staging processes. Initial socioeconomic inequalities in surgery use became undetectable at the end of the study period. The findings provide baseline information to support comparisons with patterns of clinical management in more recent years.
Authors: Elizabeth A David; James M Clark; David T Cooke; Joy Melnikow; Karen Kelly; Robert J Canter Journal: J Thorac Oncol Date: 2017-08-24 Impact factor: 15.609
Authors: Elizabeth A David; Robert J Canter; Yingjia Chen; David T Cooke; Rosemary D Cress Journal: Ann Thorac Surg Date: 2016-06-09 Impact factor: 4.330
Authors: Anders Berglund; Mats Lambe; Margreet Lüchtenborg; Karen Linklater; Michael D Peake; Lars Holmberg; Henrik Møller Journal: BMJ Open Date: 2012-05-25 Impact factor: 2.692
Authors: Gregory D Jones; Harry B Lengel; Meier Hsu; Kay See Tan; Raul Caso; Amanda Ghanie; James G Connolly; Manjit S Bains; Valerie W Rusch; James Huang; Bernard J Park; Daniel R Gomez; David R Jones; Gaetano Rocco Journal: Cancers (Basel) Date: 2021-04-15 Impact factor: 6.639
Authors: Samina Park; In Kyu Park; Eung Re Kim; Yoohwa Hwang; Hyun Joo Lee; Chang Hyun Kang; Young Tae Kim Journal: Cancer Res Treat Date: 2016-07-18 Impact factor: 4.679
Authors: Katherine E Henson; Anna Fry; Georgios Lyratzopoulos; Michael Peake; Keith J Roberts; Sean McPhail Journal: Br J Cancer Date: 2018-05-10 Impact factor: 7.640